Innovations in Women's Health Award

The last decade has witnessed a rise in products and ingredients dedicated to improving women’s health—tackling issues such as fertility, pregnancy, menstruation, menopause, pelvic health, sexual wellness and more. With so many differing health challenges across a woman’s lifetime, this new award seeks to recognize innovators with the best ingredients or products to promote women’s health, research projects specifically benefiting female health and wellness, and women-led start-ups.

    Our judging panel based their decision on the following criteria:

    • A genuine consumer demand or requirement based upon a common issue or risk factor
    • Consumer demand and interest in your format, delivery system, and/or matrix – including how innovative any delivery system is.
    • Whether your product meets a consumer demand, and how relevant the main ingredient is in meeting this demand
    • Packaging ease of use and design, including appeal and ease of use, novelty
    • Evidence that the product works for its specified use, where possible this will be product specific research, however research citing the main active ingredients solely will also be considered.
    • Solid scientific evidence to demonstrate a unique nutritional solution to this need or problem – including peer-reviewed data to back up any performance or health claims made
    • Evidence of that your product and its delivery system(s) has no, or beneficial, impact on bioavailability (especially if citing single ingredient data).
    • What gives your product the ‘X factor’ – something that makes it stand out from the crowd and edge out the competition (including evidence to back up claims)

    JUDGING PROCESS: 

    • Entries were received and reviewed by the NutraIngredients Awards Judging Panel made up of independent judges from the industry.
    • Our 2025 finalists have been confirmed and notified. 
    • Our 2025 winners will be announced during an awards' presentation in Barcelona on the Wednesday, 21st May 2025.